IN VIVO is an international peer-reviewed journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of physiology, pathology and disease management.
The topics of IN VIVO include: 1. Experimental development and application of new diagnostic and therapeutic procedures; 2. Pharmacological and toxicological evaluation of new drugs, drug combinations and drug delivery systems; 3. Clinical trials; 4. Development and characterization of models of biomedical research; 5. Cancer diagnosis and treatment; 6. Immunotherapy and vaccines; 7. Radiotherapy, Imaging; 8. Tissue engineering, Regenerative medicine; 9. Carcinogenesis.
《In Vivo》是一本由INT INST ANTICANCER RESEARCH出版商出版的专业医学期刊,该刊创刊于1987年,刊期Bimonthly,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 4区,小类学科:医学:研究与实验 4区;在JCR(Journal Citation Reports)分区等级为Q4。该刊发文范围涵盖医学:研究与实验等领域,旨在及时、准确、全面地报道国内外医学:研究与实验工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为2.406,平均审稿速度一般,3-8周。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 4区 | MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 4区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q4 | MEDICINE, RESEARCH & EXPERIMENTAL | Q4 | 2.406 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
2.406 | 54 | 99.92% | 88.06% | 未开放 | 一般,3-8周 |